In that study, we also found that optogenetically-activated corticostriatal excitatory postsynaptic currents (EPSCs) in CINs were boosted by NaP in these HD mice, because they were reduced by ranolazine, a selective antagonist of the NaP current (Tanimura et al., 2016). The gene discussed is CTNNBL1; the disease is Huntington disease.